When normal individuals eat 0.33 g protein N/kg body weight (BW) ¾ per day, they excrete 10-15 mg urea N/h per kg BW ¾ . If they now ingest (at 0 h) 0.27 (dose A), 0.40 (dose B), 0.53 (dose C), 0.94 (dose D), or 1.33 (dose E) g protein N/kg BW ¾ (in the form of casein, ovalbumin, or lactalbumin), the rate of urea N excretion accelerates within 4 h. At dose C a maximal rate of urinary urea N excretion (MRUE) is reached, which averages 55 mg urea N/h per kg BW ¾ and which persists for 16 h. Higher doses of protein do not further accelerate urea excretion, but prolong the duration of MRUE to 28 h (after dose E). Blood urea N (BUN) rises by 7-20 mg/100 ml during the first 8 h after dose C to E, and remains stable within ±5 mg/100 ml during the ensuing 8-28 h of MRUE. Each increment of protein above dose C causes a further increment in plasma a-amino N. During infusion of free amino acids at a rate of 110 or 165 mg amino acid N/h per kg BW ¾ for 12 h, rate of urea excretion increases to the MRUE value produced by dose C-E of oral protein. Higher doses of protein do not further accelerate urea excretion, but prolong the duration of MRUE to 28 h (after dose E). Blood urea N (BUN) rises by [7] [8] [9] [10] [11] [12] [13] [14] [15] [16][17][18][19][20] mg/100 ml during the first 8 h after dose C to E, and remains stable within ±5 mg/100 ml during the ensuing 8-28 h of MRUE. Each increment of protein above dose C causes a further increment in plasma a-amino N. During infusion of free amino acids at a rate of 110 or 165 mg amino acid N/h per kg BW3' for 12 h, rate of urea excretion increases to the MRUE value produced by dose C-E of oral protein.
A B S T R A C T When normal individuals eat 0.33 g protein N/kg body weight (BW)3' per day, they excrete 10-15 mg urea N/h per kg BW3'4. If they now ingest (at 0 h) 0.27 (dose A), 0.40 (dose B), 0.53 (dose C), 0.94 (dose D), or 1.33 (dose E) g protein N/kg BW3' (in the form of casein, ovalbumin, or lactalbumin), the rate of urea N excretion accelerates within 4 h. At dose C a maximal rate of urinary urea N excretion (MRUE) is reached, which averages 55 mg urea N/h per kg BW3' and which persists for 16 h. Higher doses of protein do not further accelerate urea excretion, but prolong the duration of MRUE to 28 h (after dose E). Blood urea N (BUN) rises by [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] mg/100 ml during the first 8 h after dose C to E, and remains stable within ±5 mg/100 ml during the ensuing 8-28 h of MRUE. Each increment of protein above dose C causes a further increment in plasma a-amino N. During infusion of free amino acids at a rate of 110 or 165 mg amino acid N/h per kg BW3' for 12 h, rate of urea excretion increases to the MRUE value produced by dose C-E of oral protein.
These findings indicate that MRUE corresponds to a period of maximal rate of urea synthesis (MRUS) . MRUS is greater than MRUE because one fraction of newly formed urea is hydrolyzed in the gastrointestinal tract, and another fraction may accumulate temporarily in body water during the MRUE period. Oral neomycin reduces the proportion of urea hydrolyzed in the gut to less than 20%; its extent is measured by recovery in the urine of a tracer dose of ["4C]urea injected intramuscularly during determination of MRUE. Accumulation of urea in body water is estimated from increment in BUN during the period of MRUE measurement (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) h after dose E of casein) and from body water INTRODUCTION Hepatic enzymes incorporate NH3 and the amino groups of amino acids into urea, the principal end-product of N metabolism. In normal subjects, the rate of urea production is known to be proportional to protein intake, but the maximal rate which can be achieved has not been measured. In cirrhotic patients, a reduced capacity to synthesize urea is suggested by elevated concentrations of NH3 and amino acids, and by depressed concentration of urea, in blood or plasma. But in these patients, too, the maximal rate has not been measured, so the extent of this impairment is not known.
Preliminary experiments have shown that a maximal rate of urea N excretion (MRUE) 1 In all 44 subjects, fasting BUN was less than 20 mg/100 ml, plasma creatinine concentration was less than 1.0 mg/ 100 ml, and creatinine clearance was greater than 80 ml/ min per 1.73 m2 surface area.
Patients received the following daily diet divided into four equal aliquots at 6- (2) . After each dose, the rate of urea excretion accelerated ( Fig. 1) . Progression from Dose A-C increased peak rate of excretion; after doses D and E, peak rate was not further increased but its duration was progressively lengthened. Peak rate after dose E, which persisted for 20-28 h, was termed the maximal rate of urea excretion (MRUE). Casein, lactalbumin, and ovalbumin influenced urea excretion in the same way (Table I) . After dose E of each protein, average MRUE of six normal individuals was 50-55 mg urea N/h per kg BW314; for each protein, this rate was maintained 20 h or longer.
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During the period of MRUE after dose E, BUN was generally stable (±5 mg/100 ml) at a level 5-12 mg/100 ml higher than before the protein supplement (Table II) . 'For a 70 kg subject these doses are: A, 40 g protein; B, 60 g protein; C, 80 g protein; D, 140 g protein; E, 200 g protein. In experiments involving dose E in four normal and in six cirrhotic subjects weighing 51-62 kg, stools collected during the 72 h (a) before and (b) after 8 a.m., day 4, were analyzed for N. In each case, N content of collection (b) minus that of collection (a) was less than 2 g. Thus, more than 92%7o of dose E had been absorbed.
Blood NH3 concentration did not rise. Plasma AAN (normal fasting range, 6.0-7.5 mg/100 ml) rose progressively, reaching a peak of 10.1-13.4 mg/100 ml at 24 h (Table I) . Each dose of protein (A-F) caused a progressively higher peak in plasma AAN (Table I ).
The period of MRU,E, accompanlied by a stable BUN, could correspond( to a maximal rate of urea synthesis in the liver, or to a maximal rate of protein tligestion-aminio acid absorptioni in the gastrointestinal tract. To clarify this point, two intravenous experiments were done in each of six normal subjects (Table III) . The amino acid mixture was infused for 12 h at a rate either two times (first experiment) or three times (secontl experimenit) the average normal MRUE, i.e., at a rate of 110 or 165 mg amino acid N/h per kg BWR31. A maximal rate of urea excretion was established by 8 h and persisted for 12-16 h; in each individual, this rate in both first and second intravenous experiment was within +157% of the MRUE value observed after oral dose E of casein. In six normal subjects, MRUE determined (a) by dose E of casein, (b) by infusion of 110 mg amino acid N/h per kg BW"', (c) by infusion of 165 mg amino acid N/h per kg BW"4, did not differ significantly (P < 0.05) 3 (Table III) .
Cirrhotic patients. In six cirrhotic patients selected for preliminary study (Table I) , relationships between oral protein supplement, urea excretion, AAN, and NH3 differed from those in healthy individuals in these respects: (a) MRUE was achieved at a lower dose of protein (usually dose B or C) than in normal subjects (Fig. 1 , Table   I ). (b) MRUE averaged 40%o of normal (P < 0.005).
(c) MRUE at a specified dose of protein (B-E) lasted two to four times longer than in normal individuals (Table  I) . (d) Peak elevation in plasma AAN at a specified dose of protein was 10-30% greater than in the normal group (Table I ), but the difference was not significant at 0.05 level. (e) Blood NH3 concentration, which did not increase significantly after dose E in the normal individuals, rose by 80-250 Ag/lOO ml in the cirrhotic subjects (Table III) (P < 0.001 for difference between normals and cirrhotics).
We concluded that in both normal and cirrhotic subjects, the period of MRUE after oral ingestion of protein at dose E corresponded to a period of MRUS. But the observed 'Unless otherwise stated, P values were calculated by Student's t test (both tails). (ACi "C urea injected). The interval 8-24 h after beginning ingestion of dose E casein was selected as the period for measuring MRUE (Fig. 1) Protocol for measuring MRUS For 9 days, subjects ate the "basic diet" and received 2.0 g neomycin at 8-h intervals. Urea N was measured in each 4 h urine collection. On day 4, BUN was determined at 8 a.m. and dose E of casein was ingested; 4 gCi ['4C]urea was injected intramuscularly. BUN was measured at 6-h intervals for the next 24 h. Urine urea "C counts were measured in each 4 h urine collection through day 5. On day 8, body H20 space was determined. The data and calculations of a typical experiment are shown in Table II. MRUS in normal and cirrhotic subjects MRUS averaged 65 mg urea N/h per kg BW3/' (range 55-76) in 10 normal subjects, and 27 mg urea N/h per kg BW3/' (range 6-64) in 34 cirrhotic subjects (Table IV) 19 cirrhotic subjects were observed on a 40 g protein diet for 10 days without neomycin. On days 8-10, electroencephalogram (EEG) and neurologic status were graded according to Parsons-Smith, Summerskill, Dawson, and Sherlock (13); these were grade 0, A, or B for EEG and grade 0 or I for neurologic status. AAN and NH8 were also measured. The patients were then observed for three successive periods of 10 days (or less, if hepatic encephalopathy was precipitated) on a diet of 60, 80, and of 100 g protein daily, neomycin being withheld. On days 7-10, or sooner if encephalopathy occurred (as manifested by EEG of grade C, D, or E and neurologic status of grade III or IV), the EEG, fasting blood NH3 and plasma AAN were measured.
The results are given in Tables IV and VI, where the  patients are arranged in groups I, II, III, IV, Within the cirrhotic category, the correlation between MRUS and sensitivity to NH,Cl was significant at the 0.01 level (Table IV) . MRUS showed little or no correlation with concentrations of albumin, bilirubin, or hemoglobin (Table IV) . DISCUSSION The MRUE which occurs after oral ingestion of protein at doses C E in normiials and at doses B > E in cirrhotics ( Fig. 1) could be determiined by (1) the maximiial capacity to syntlhesize urea in the liver, or (2) the nmaximal capacity to digest protein and absorb amino acids in the gastrointestinal tract. Proof of (1) is: (a) a progressively greater accumulation of plasma amino acids with each incremiient in oral protein through the entire range of doses, including those greater than the dose required to establish MIRUE; (b) equivalence of MRUE value during infusion of amino acids to that produced by dose E of casein (Table IV) . If The steps by which the N of plasma amino acids is converted to urea N are shown in Fig. 2 . In normal subjects, during the period of MRUS, amino acids accumulate in plasma but NH3 does not. Therefore, the rate-limiting steps in urea synthesis in normal individuals miust be transport of amino acids from extra-to intracellular space, or enzymatic processes I, II, or III of Fig. 2 . In patients with chronic liver disease, the even greater accumulation of plasma amino acids during the period of MRUS (Table IV) suggests impaired transport of amino acids into liver cells (which could result from reduction of portal blood flow, or from dysfunction of cellular transport mechanisms, or both), or reduced activity of the hepatic enzymes responsible for processes I, II, and III in Fig. 2 . Simultaneous accumulation of NHs in these patients indicates additional rate-limiting step(s) which had not been saturated by dose E in the normals: either VI, VII, IX, or XI (Fig. 2) . The activities of the enzymes which catalyze I, II, III, V, and VII will need to be compared in normal and cirrhotic livers in order to distinguish these possibilities. 
